Bis(aminomethyl)phosphinic Acid, a Highly Promising Scaffold for the Development of Bacterial Urease Inhibitors.

Katarzyna Macegoniuk, Anna Dziełak, Artur Mucha, Łukasz Berlicki
Author Information
  1. Katarzyna Macegoniuk: Department of Bioorganic Chemistry, Faculty of Chemistry, Wrocław University of Technology , Wybrzeże Wyspiańskiego 27, 50-370 Wrocław, Poland.
  2. Anna Dziełak: Department of Bioorganic Chemistry, Faculty of Chemistry, Wrocław University of Technology , Wybrzeże Wyspiańskiego 27, 50-370 Wrocław, Poland.
  3. Artur Mucha: Department of Bioorganic Chemistry, Faculty of Chemistry, Wrocław University of Technology , Wybrzeże Wyspiańskiego 27, 50-370 Wrocław, Poland.
  4. Łukasz Berlicki: Department of Bioorganic Chemistry, Faculty of Chemistry, Wrocław University of Technology , Wybrzeże Wyspiańskiego 27, 50-370 Wrocław, Poland.

Abstract

Inhibitors of bacterial ureases are considered to be promising compounds in the treatment of infections caused by Helicobacter pylori in the gastric tract and/or by urealytic bacteria (e.g., Proteus species) in the urinary tract. A new, extended transition state scaffold, bis(aminomethyl)phosphinic acid, was successfully explored for the construction of effective enzyme inhibitors. A reliable methodology for the synthesis of phosphinate analogues in a three-component Mannich-type reaction was elaborated. The obtained molecules were assayed against ureases purified from Sporosarcina pasteurii and Proteus mirabilis, and aminomethyl(N-n-hexylaminomethyl)phosphinic acid was found to be the most potent inhibitor, with a K i = 108 nM against the S. pasteurii enzyme.

Keywords

References

  1. Amino Acids. 2012 May;42(5):1937-45 [PMID: 21559954]
  2. J Med Chem. 2011 Sep 8;54(17):5955-80 [PMID: 21780776]
  3. Gastroenterology. 1998 Jan;114(1):58-70 [PMID: 9428219]
  4. Urol Res. 1979 Sep;7(3):215-21 [PMID: 388798]
  5. J Biochem. 1967 Sep;62(3):293-9 [PMID: 5586497]
  6. J Med Chem. 2008 Sep 25;51(18):5736-44 [PMID: 18717581]
  7. Infect Immun. 1991 Jul;59(7):2470-5 [PMID: 2050411]
  8. FEBS Lett. 2003 Dec 4;555(2):367-70 [PMID: 14644444]
  9. J Clin Pathol. 2010 May;63(5):424-30 [PMID: 20418234]
  10. J Am Chem Soc. 1975 Jul 9;97(14):4130-1 [PMID: 1159215]
  11. Expert Opin Ther Pat. 2011 Jun;21(6):945-57 [PMID: 21457123]
  12. Bioorg Med Chem. 2007 Jun 1;15(11):3703-10 [PMID: 17400458]
  13. J Enzyme Inhib Med Chem. 2002 Aug;17(4):247-53 [PMID: 12530477]
  14. J Med Chem. 2010 Aug 12;53(15):5597-606 [PMID: 20684601]
  15. Am J Vet Res. 1986 Dec;47(12):2604-11 [PMID: 3800119]
  16. J Enzyme Inhib. 2001 Dec;16(6):507-16 [PMID: 12164390]
  17. Eur J Med Chem. 2010 Nov;45(11):5064-70 [PMID: 20801557]
  18. Biochim Biophys Acta. 1962 Dec 4;65:380-3 [PMID: 14033904]
  19. Bioorg Med Chem. 1995 May;3(5):605-10 [PMID: 7648208]
  20. Microbiol Rev. 1995 Sep;59(3):451-80 [PMID: 7565414]
  21. J Biochem. 1985 Dec;98(6):1681-8 [PMID: 3841542]
  22. J Clin Microbiol. 1987 Nov;25(11):2216-7 [PMID: 3320089]
  23. Curr Med Chem. 2002 Jul;9(14):1323-48 [PMID: 12132990]
  24. J Biol Chem. 1965 Jun;240:2407-14 [PMID: 14304845]
  25. Urol Int. 2007;79 Suppl 1:32-6 [PMID: 17726350]
  26. Eur Urol. 1991;20(3):243-7 [PMID: 1726639]
  27. Dig Dis Sci. 1998 Jan;43(1):109-19 [PMID: 9508511]
  28. Int J Antimicrob Agents. 2002 Jun;19(6):488-98 [PMID: 12135839]
  29. J Biol Inorg Chem. 2000 Feb;5(1):110-8 [PMID: 10766443]

Word Cloud

Created with Highcharts 10.0.0ureasesaminomethylphosphinicInhibitorstracturealyticbacteriaProteusacidenzymeMannich-typereactionpasteuriiinhibitorbacterialconsideredpromisingcompoundstreatmentinfectionscausedHelicobacterpylorigastricand/oregspeciesurinarynewextendedtransitionstatescaffoldbissuccessfullyexploredconstructioneffectiveinhibitorsreliablemethodologysynthesisphosphinateanaloguesthree-componentelaboratedobtainedmoleculesassayedpurifiedSporosarcinamirabilisN-n-hexylaminomethylfoundpotentK=108nMSBisAcidHighlyPromisingScaffoldDevelopmentBacterialUrease

Similar Articles

Cited By